Pharmacy

Doctors Without Borders is urging drugmakers that manufacture tuberculosis medications to significantly lower their prices ahead of a major tuberculosis conference, according to STAT. 

Johnson & Johnson's third quarter earnings beat Wall Street's expectations, despite the mounting losses coming from thousands of lawsuits, according to CNBC.

Ned Sharpless, MD, the FDA's acting commissioner, said Oct.16 that the agency broke its record for most generic drug approvals this year.

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.

Viatrexx is recalling 19 lots of its 10 mL sterile injectable vials of various products because they were manufactured in a way that cannot guarantee sterility.

Walgreens Boots Alliance, insurer Centene and pharmacy benefit manager RxAdvance are partnering on a cloud-based pharmacy benefit platform. 

Beverly Sackler, matriarch of the family that owns Purdue Pharma, has died, according to The New York Times. 

The FDA has named Torrent Pharmaceuticals one of the main culprits behind the manufacturing of tainted blood pressure medicines. 

Although the rate of drug list price increases has slowed in the last decade, the average launch price for a brand name drug entering the market has skyrocketed, according to a new report from drug research firm 46brooklyn.

The FDA approved Eli Lilly's new migraine drug, Reyvow, making it the drugmaker's second migraine drug approval this year.